Dynatronics Corporation

Equities

DYNT

US2681575005

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-15 pm EDT			5-day change	1st Jan Change
0.3704 ^USD	-5.27%		-6.82%	-36.68%

Feb. 08	Transcript : Dynatronics Corporation, Q2 2024 Earnings Call, Feb 08, 2024
Feb. 08	Earnings Flash (DYNT) DYNATRONICS Reports Q2 Revenue $8.2M	MT

Dynatronics Corporation Provides Net Sales Guidance for the Fourth Fiscal Quarter Ended June 30, 2021

August 09, 2021 at 04:01 pm EDT

Dynatronics Corporation provided net sales guidance for the fourth fiscal quarter ended June 30, 2021. The Company announced that it expects fourth fiscal quarter ended June 30, 2021 net sales to be approximately $12.1 million.

Latest news about Dynatronics Corporation

Transcript : Dynatronics Corporation, Q2 2024 Earnings Call, Feb 08, 2024	Feb. 08
Earnings Flash (DYNT) DYNATRONICS Reports Q2 Revenue $8.2M	Feb. 08	MT
Dynatronics Corporation Provides Sales Guidance for the Full Year 2024	Feb. 08	CI
Dynatronics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 07	CI
Dynatronics Corporation Announces Board and Committee Changes	Jan. 16	CI
Tranche Update on Dynatronics Corporation's Equity Buyback Plan announced on February 14, 2011.	Nov. 13	CI
Transcript : Dynatronics Corporation, Q1 2024 Earnings Call, Nov 09, 2023	Nov. 09
Earnings Flash (DYNT) DYNATRONICS Reports Q1 Revenue $9.4M	Nov. 09	MT
Dynatronics Corporation Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 09	CI
Dynatronics Corporation Announces CFO Changes	23-10-30	CI
North American Morning Briefing : Treasury Yields -2-	23-10-10	DJ
Ladenburg Thalmann Downgrades Dynatronics to Neutral From Buy, Cuts Price Target to $3.80 From $6.50	23-10-09	MT
Dynatronics Corporation Appoints John Krier as Interim Chief Financial Officer	23-10-02	CI
Dynatronics Corporation Appoints John Krier as Interim Principal Accounting Officer	23-10-02	CI
Tranche Update on Dynatronics Corporation's Equity Buyback Plan announced on February 14, 2011.	23-09-28	CI
Dynatronics Corporation Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-28	CI
Earnings Flash (DYNT) DYNATRONICS Posts Q4 Revenue $8.4M	23-09-28	MT
Dynatronics Corporation Provides Revenue Guidance for the Fiscal Year 2024	23-09-28	CI
Transcript : Dynatronics Corporation, Q4 2023 Earnings Call, Sep 28, 2023	23-09-28
North American Morning Briefing : Rising Oil -2-	23-09-28	DJ
Dynatronics Corporation Announces Executive Changes	23-05-18	CI
Dynatronics Corporation Announces Chief Executive Officer Changes	23-05-18	CI
Tranche Update on Dynatronics Corporation's Equity Buyback Plan announced on February 14, 2011.	23-05-11	CI
Dynatronics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-11	CI
Transcript : Dynatronics Corporation, Q3 2023 Earnings Call, May 11, 2023	23-05-11

Chart Dynatronics Corporation

Duration

Period

More charts

Company Profile

Dynatronics Corporation is a medical device company engaged in providing restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, the Company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The Company's products are marketed under a portfolio of brands, including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others. Its orthopedic soft bracing products are designed to accelerate health for patients both pre- and post-surgical intervention, and during fracture recovery, joint stabilization, and ligament injury. The Companyâs Solaris, Hausmann, PROTEAM, and Mammoth brands include products for physical therapy, rehabilitation, and athletic training.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-13 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.3704 USD

Average target price

4 USD

Spread / Average Target

+979.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
DYNATRONICS CORPORATION	-36.68%	1.81M
THERMO FISHER SCIENTIFIC	+5.10%	213B
DANAHER CORPORATION	+3.60%	177B
INTUITIVE SURGICAL, INC.	+11.86%	134B
BOSTON SCIENTIFIC CORPORATION	+16.66%	99.13B
SIEMENS HEALTHINEERS AG	+0.57%	63.47B
EDWARDS LIFESCIENCES CORPORATION	+16.98%	53.69B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-4.51%	46.36B
AGILENT TECHNOLOGIES, INC.	+0.86%	41.09B
GE HEALTHCARE TECHNOLOGIES INC.	+11.39%	39.3B

Other Advanced Medical Equipment & Technology